Shopping Cart
- Remove All
- Your shopping cart is currently empty
Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) targeted against waveform proteins, exhibiting anti-HBV properties and potential applications in rheumatoid arthritis research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $197 | In Stock | |
5 mg | $496 | In Stock | |
10 mg | $745 | In Stock | |
25 mg | $1,120 | In Stock | |
50 mg | $1,490 | In Stock | |
100 mg | $1,980 | In Stock |
Description | Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) targeted against waveform proteins, exhibiting anti-HBV properties and potential applications in rheumatoid arthritis research. |
Alias | hzVSF-v13 |
Cas No. | 2460809-80-5 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.